Success Metrics

Clinical Success Rate
72.7%

Based on 16 completed trials

Completion Rate
73%(16/22)
Active Trials
1(4%)
Results Posted
56%(9 trials)
Terminated
6(24%)

Phase Distribution

Ph phase_3
5
20%
Ph phase_2
6
24%
Ph phase_4
10
40%
Ph not_applicable
4
16%

Phase Distribution

0

Early Stage

6

Mid Stage

15

Late Stage

Phase Distribution25 total trials
Phase 2Efficacy & side effects
6(24.0%)
Phase 3Large-scale testing
5(20.0%)
Phase 4Post-market surveillance
10(40.0%)
N/ANon-phased studies
4(16.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

16 of 22 finished

Non-Completion Rate

27.3%

6 ended early

Currently Active

1

trials recruiting

Total Trials

25

all time

Status Distribution
Active(1)
Completed(16)
Terminated(6)
Other(2)

Detailed Status

Completed16
Terminated6
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
1
Success Rate
72.7%
Most Advanced
Phase 4

Trials by Phase

Phase 26 (24.0%)
Phase 35 (20.0%)
Phase 410 (40.0%)
N/A4 (16.0%)

Trials by Status

completed1664%
terminated624%
active_not_recruiting14%
unknown28%

Recent Activity

1 active trials
Showing 5 of 25
completedphase_2

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

NCT03844412
active_not_recruitingphase_4

Management of Acute Tinnitus With Migraine Medications

NCT06799169
terminatedphase_4

Pediatric Concussion Outcomes

NCT04226365
terminatedphase_3

Nortriptyline for the Treatment of Functional Dyspepsia

NCT03652571
completedphase_3

Antidepressants Trial in Parkinson's Disease

NCT03652870
View all 25 trials

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT03844412Phase 2

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Completed
NCT06799169Phase 4

Management of Acute Tinnitus With Migraine Medications

Active Not Recruiting
NCT04226365Phase 4

Pediatric Concussion Outcomes

Terminated
NCT03652571Phase 3

Nortriptyline for the Treatment of Functional Dyspepsia

Terminated
NCT03652870Phase 3

Antidepressants Trial in Parkinson's Disease

Completed
NCT02169830Not Applicable

Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine

Terminated
NCT02918097Phase 4

Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode

Completed
NCT02901249Phase 4

Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder

Completed
NCT02260388Phase 4

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations

Completed
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT00009672Phase 2

Pain Treatment for Sciatica

Completed
NCT00547703Not Applicable

Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia

Terminated
NCT00062738Phase 2

Treatment of Depression in Parkinson's Disease Trial

Completed
NCT00000378Phase 4

Antidepressant Treatment of Melancholia in Late Life

Completed
NCT00660062Phase 4

Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)

Terminated
NCT02237937Phase 4

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

Unknown
NCT00045916Phase 4

Optimizing Electroconvulsive Therapy for Depression

Completed
NCT01896349Not Applicable

Interpersonal Psychotherapy for Treatment Resistant Depression

Unknown
NCT00000377Not Applicable

Preventing the Return of Depression in Elderly Patients

Completed
NCT01065649Phase 3

Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients

Completed

Drug Details

Intervention Type
DRUG
Total Trials
25